Hearing Performance Articles & Analysis
1 news found
According to SMI, both the interim safety and accuracy results of LuViva justify the completion of the clinical study and submission of the data to the NMPA as soon as practicable. “We are pleased to hear that LuViva has performed well and as expected in the first clinical trials in China,” said Gene Cartwright, CEO of Guided Therapeutics. ...